People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Okami Medical, Inc. | — | Healthtech | Series B | $77.2M | $125.6M | 2016 |
| Inari Medical, Inc. | — | Healthtech | Series B | $51.9M | $669.2M | 2011 |
Robert Rosenbluth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Robert Rosenbluth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jonathan Root | 2 | 16 |
| Kirk Nielsen | 2 | 13 |
| Brian Cox | 2 | 5 |
| Paul Lubock | 2 | 3 |
| Donald Milder | 2 | 2 |
| William Hoffman | 1 | 3 |
| Brian J. Cox | 1 | 3 |
| Rhonda Robb | 1 | 2 |
| Mike Kramer | 1 | 1 |
| Andrew Hykes | 1 | 1 |
| William H. Hoffman | 1 | 1 |
| Paul H. Lubock | 1 | 1 |
| Kirk H. Nielsen | 1 | 1 |
| Brian H. Cox | 1 | 1 |
| Donald H. Milder | 1 | 1 |
| Robert H. Rosenbluth | 1 | 1 |
| Jonathan H. Root | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.